Bestpharma Sp. z o.o.
Carrying personalization through the coating line
- Pharmaceuticals — proprietary tablet coatings and specialty ingredients
- Warsaw, Poland
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Bestpharma Sp. z o.o.'s published strategy and is not endorsed by, or produced in cooperation with, Bestpharma Sp. z o.o.. Company website
Strategic priorities
Bestpharma has built a reputation on Personalization: proprietary Bestcoat, Gocoat, Nutricoat and Perica tablet-coating systems developed and manufactured in Poland, alongside a global sourcing operation for marine oils, algal oils and collagens. The leadership under Mateusz Poddębniak has publicly framed the next phase as aligning "family business tradition" with "modern management" and international expansion, with a stated goal of increasing sales in foreign markets.
The technical challenge is the collision between that personalization model and the day-to-day operations it creates. Custom colour, flavour-masking and titanium-dioxide-free coatings mean frequent line changeovers; marine-oil and collagen ingredients sourced "from the farthest corners of the world" carry temperature risk; CITES (the Convention on International Trade in Endangered Species) paperwork and quality documentation span two product families. The same company that can run a complex formulation pipeline also keeps a paper-driven quality record.
The 2025 financial picture is a healthy one. Net profit growth of 25.4 percent and total equity growth of 109.5 percent give the company the capital headroom to invest in the digital tools that personalization at scale requires — and the choice now is whether the R&D, coating and supply-chain data stay in separate conversations or move into one operational picture.
-
01
100% Digital Lab Vision
Moving the R&D department from manual substance searching to automated, data-rich research cycles through LIMS (Laboratory Information Management System) and lab automation, so a new formulation arrives in production with a documented trail rather than as tribal knowledge.
-
02
Personalization at Scale
Supporting custom colour, flavour-masking and TiO2-free (titanium-dioxide-free) coating requests without expanding shifts, by reducing changeover time and material waste through simulation and sequenced batch planning.
-
03
Sustainable Manufacturing Leadership
Turning "ecological responsibility" from a statement into measured numbers — automated energy, water and supply-chain emissions data that can be presented to multinational pharmaceutical partners on request.
-
04
Global Market Expansion
Unifying Warsaw headquarters with localized production and international warehouses through cloud-based ERP and OT (Operational Technology) integration, supporting the stated goal of increasing sales in foreign markets.
Challenges we see
- Operations Manufacturing
Scheduling frequent changeovers on the coating line
Bestcoat, Gocoat, Nutricoat and Perica are developed and manufactured in Poland for client-specific colour, flavour-masking and TiO2-free formulations. Personalization is the central value proposition, and the cost of producing one of those batches shows up in changeover time, cleaning time and the risk of batch-to-batch carry-over.
Where the line switches between formulations often, the question for the scheduler is not whether to change, but how to sequence a hundred small runs so that the line is the right state for the next one — a sequencing problem before it is an equipment problem.
- Operations Supply Chain
Sourcing marine oils and collagens under temperature risk
Marine oils, algal oils and collagens are sourced from global origins, where temperature excursions in transit can compromise oxidative stability. Bestpharma offers an "assurance in writing" quality guarantee on every batch leaving the Warsaw warehouse.
For ingredients whose integrity is temperature-bound, the relevant question is whether the proof of condition is something that can be shown to a customer after the fact, or whether it is captured as data during transit and travels with the shipment.
- Data Integration
Moving optimized formulations from the lab to the line
R&D develops new substances and optimized formulations, while production runs separate automation. The data the lab generates on a successful formulation is not currently transferred as machine-readable parameters; the gap between a validated lab recipe and a production batch rests on manual steps.
The cost of the lab-to-line boundary rises with the rate of new formulations. As more candidates move through R&D, the case for a single parameters record that the line can read directly — and that the lab can update — grows with it.
- Compliance Regulatory
Documenting CITES and quality records across two product families
Bestpharma operates under the Washington Convention on International Trade in Endangered Species (CITES) for marine and plant-derived ingredients, and guarantees that "every product that leaves the warehouse" meets rigorous quality criteria. Quality documentation spans Human Health and Animal Health product lines.
Where quality records live across paper forms and disconnected systems, audit preparation becomes an exercise in retrieval rather than inspection. The question is what each batch looks like in the system, and whether the system itself can answer it.
- Compliance Cybersecurity
Protecting proprietary coating formulations as competitive IP
The third-generation Bestcoat formula and the wider proprietary coating portfolio are the company's most valuable competitive assets in the TiO2-free segment. Standard office IT infrastructure protects them today; OT-side cybersecurity specific to a pharmaceutical manufacturer is not in place.
As the company's differentiation moves into formulations that live in lab and production systems, the security boundary moves with it — and what is now an IP-protection question increasingly looks like an OT (Operational Technology) cybersecurity question.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Simulating coating changeovers before they run
Coating line changeovers are frequent because personalization is the operating model. Without predictive scheduling and process simulation, each changeover consumes cleaning time and material, and the order in which personalized runs are sequenced is set by experience rather than by analysis.
A digital twin (a software replica of the physical process) of the Bestcoat, Gocoat and Nutricoat coating operations — built from spray rate, atomization pressure, drying temperature and historical run data — lets Bestpharma evaluate changeover sequences and formulation parameter sets before committing a batch, recovering capacity that currently goes to non-value-adding transition time.
- Bestpharma, About — company mission and Personalization positioning
- Bestpharma, Bestcoat product page — third-generation TiO2-free formulation
-
Recording cold-chain condition as data, not attestation
Marine oils, algal oils and collagens travel from global origins to the Warsaw warehouse with a paper-based chain of custody. Temperature excursions in transit are detectable only after the fact, and the "assurance in writing" Bestpharma offers is currently an attestation rather than a measured record.
IoT (Internet of Things) sensors in shipping containers measure temperature, humidity and light exposure continuously, and the resulting excursion data travels with the batch record. A scanned code on the finished product returns the chain of custody to the customer, replacing trust with a measured history.
- Bestpharma, About — sourcing from "the farthest corners of the world"
- Bestpharma, Quality statement — "assurance in writing"
-
Linking R&D formulations to production parameters as one record
Validated formulations developed in the R&D lab are not transferred to the coating line as machine-readable parameters. The lab record and the production record are separate conversations, and the boundary between them is filled by manual transcription and operator memory.
Connecting the LIMS and the line-side automation through OPC UA (Open Platform Communications Unified Architecture) or MQTT (a lightweight messaging protocol common in industrial IoT) means a successful formulation in the lab becomes a set of operating parameters the line can load directly. The lab's "recipe" version, the line's run parameters and the resulting batch record reference the same source.
- Bestpharma, About — R&D substance research and Personalization
- Bestpharma, Bestcoat — coating process described as precision science
-
Putting CITES and quality documentation on a single digital record
CITES paperwork, batch release records and quality documentation span paper forms and disconnected digital logs across Human Health and Animal Health product families. Audit preparation is a retrieval exercise rather than a query against a maintained system.
A digital Quality Management System (QMS) holds batch records, deviation reports, change controls and CITES documentation in one record per batch, with electronic signatures and a complete audit trail. CITES compliance becomes a property of the batch record rather than a folder maintained alongside it.
- Bestpharma, Quality statement — "every product that leaves the warehouse"
- Bestpharma, About — CITES / Washington Convention compliance
-
Turning carbon and energy claims into measured numbers
Bestpharma's stated commitment to ecological responsibility is qualitative. Manufacturing energy and supply-chain emissions are not currently captured at the level of detail that multinational pharmaceutical partners ask for in supplier qualification.
IoT meters on coating equipment and utilities capture energy and water per batch, and a Scope 3 emissions (indirect emissions across the value chain) layer reads logistics emissions from carriers' data feeds. The resulting ESG (Environmental, Social and Governance) reports are produced from live data rather than assembled annually.
- Bestpharma, About — ecological responsibility and CITES operations
- Bestpharma, Quality — sustainability commitments
What we'd propose
- Digital CDMO
Digital twin of the coating line for changeover sequencing
A simulation model of Bestpharma's Bestcoat, Gocoat, Nutricoat and Perica coating operations, built from spray rate, atomization pressure and drying-temperature data, used to sequence personalized batches and to test parameter sets before they are run on the line.
-
Process simulation model
Build a digital replica of each coating line from controller data: spray rate, atomization pressure, drying temperature and cleaning cycle time. The model carries enough detail that a candidate sequence of personalized runs can be evaluated against it before any of those runs are scheduled on the line.
-
Changeover sequencing optimizer
Recommend the order in which a set of personalized runs should be produced, minimizing cleaning time and material loss across the sequence. Operators see the recommended sequence and the reasoning behind it, so the schedule is a recommendation they can override with their own judgement.
-
Lab-to-line parameter transfer
Take the validated formulation parameters from the lab's LIMS record and load them as set-points on the coating line, so the recipe the lab signed off on is the recipe the line runs.
- Capacity for personalized runs grows from reduced transition time, without adding shifts.
- The schedule the line receives is the schedule the simulation supported, with the reasoning visible.
- Validated formulation parameters reach the line as data, not as transcribed notes.
-
- Enterprise AI
Cold-chain monitoring with a per-batch digital history
An IoT and data-platform programme that records temperature, humidity and light exposure for marine oil, algal oil and collagen shipments from origin to Warsaw warehouse, and produces a per-batch digital history that travels with the product.
-
Sensor-equipped shipping containers
Deploy IoT sensors in containers carrying marine oils, algal oils and collagens. The sensors measure temperature, humidity and light exposure continuously and transmit their readings through cellular connectivity so excursions are visible while the shipment is still in transit, not after it has arrived.
-
Excursion alerts and batch disposition
Configure ingredient-specific temperature bands. When a shipment leaves its band, the system notifies both Bestpharma and the supplier so the shipment can be held, inspected or rejected before its contents enter a coating batch.
-
Per-batch chain-of-custody record
Bind the in-transit sensor record to the inbound material lot, then to the finished Bestpharma product, so a scanned code on a delivered batch returns the temperature, humidity and light history of the ingredients inside it.
- Ingredient integrity is a measured property of the shipment, available to customers on request.
- Excursions become decisions made in transit rather than rejections made at goods-in.
- The "assurance in writing" promise is backed by per-batch data.
-
- Digital Lab
LIMS connecting R&D, QC and the coating line
A Laboratory Information Management System (LIMS) that connects the R&D laboratory's substance-research and stability-testing workflows with quality control and the coating line's automation, so a validated formulation becomes a production-ready parameter set.
-
Sample and study lifecycle tracking
Each sample and study in the R&D and QC labs has one digital record — barcode- or RFID-tagged, with method version, instrument identity and timestamp attached. The record covers receipt, preparation, analytical work and disposition, and is the same record a regulatory submission references.
-
Instrument integration via OPC UA
Connect balances, spectrometers and stability chambers through OPC UA (Open Platform Communications Unified Architecture, a vendor-neutral industrial data-exchange standard) so the result leaves the instrument as structured data with its own audit trail, rather than as a printed report transcribed into the record by hand.
-
Formulation database with version-controlled recipes
Hold proprietary coating recipes in a versioned, approval-controlled database. The recipe version on a production run is the recipe the lab released, with the parameters exported to the line as a single, traceable change.
- Validated formulations reach the line with their provenance intact.
- Manual transcription between the lab and the batch record disappears.
- A new formulation becomes a data event, not a coordination exercise.
-
- Digital Lab
Digital QMS with a CITES-aware batch record
A digital Quality Management System (QMS) covering batch records, deviations, change controls and CITES compliance documentation across Bestpharma's Human Health and Animal Health product families, with one record per batch.
-
Electronic batch records with e-signatures
Replace paper batch records with electronic workflows that enforce process steps, capture operator signatures under 21 CFR Part 11 (the US FDA rule on electronic records and electronic signatures), and automatically compile release documentation at the end of the run.
-
CITES compliance module
Link each ingredient batch to its species, import permit and CITES documentation automatically. The finished-product batch record carries the chain of permits and species certifications it relied on, ready for inspection.
-
Audit readiness view
A management dashboard shows documentation completeness, pending deviations and open change controls across both product families, so a customer or regulatory audit arrives at a known state rather than a discovered one.
- Audit preparation becomes a query, not a retrieval exercise.
- CITES paperwork follows the ingredient lot, instead of being maintained alongside it.
- The Human Health and Animal Health lines share a documentation standard, without losing their separation.
-
- Agents
AI agents for formulation, CITES and tech-transfer documents
Narrow, reviewable agents that draft the repetitive part of formulation change histories, CITES compliance packets and technology-transfer documents from source records in the LIMS and QMS, with a named reviewer approving every output.
-
Drafting from LIMS and QMS records
Generate the first draft of a formulation change history, a CITES compliance packet for an inbound shipment, or a technology-transfer document directly from the underlying LIMS and QMS records. The author edits and judges rather than assembles from scratch.
-
Template and completeness check
Check a draft against Bestpharma's own template and the CITES, GMP (Good Manufacturing Practice) or customer-specific checklist it has to satisfy, returning missing or inconsistent sections before the document reaches a human reviewer.
-
Change-impact search across the document set
When a Bestcoat formulation, a supplier or a CITES-listed species status changes, retrieve every controlled document that references it and rank them by how directly they are affected, so the update scope is known on day one.
- Specialist time moves from assembling documents to judging them.
- Documents arrive at review complete, against the template that has to be met.
- Every output is traceable to the source records it came from, and signed off by a named reviewer.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what Bestpharma Sp. z o.o.'s own published ambition implies — not a perfect score.
- Lab-to-line data 30 → 75
- Validated R&D formulations are not currently transferred to the coating line as machine-readable parameters, and the boundary between them is filled by manual steps. A connected LIMS and recipe database would close it.
- Coating line automation 38 → 80
- Personalization produces frequent changeovers, and the sequence in which personalized runs are scheduled is currently set by experience. A process simulation model would let that sequence be evaluated before the line sees it.
- Quality documentation 28 → 72
- Quality records span paper forms and disconnected digital logs across two product families. A digital QMS with one record per batch would give audit preparation a maintained source.
- Cold-chain visibility 22 → 65
- Marine oil, algal oil and collagen shipments are sourced globally with a paper-based chain of custody. Continuous in-transit environmental data would convert the "assurance in writing" promise into a measured one.
- OT cybersecurity 32 → 72
- Standard office IT infrastructure protects proprietary coating formulations today. As the differentiation moves into formulations that live in lab and production systems, the security boundary has to move with them.
- ESG data capture 18 → 60
- Sustainability commitments are qualitative. Per-batch energy, water and supply-chain emissions data would let ESG reports be produced from live operations data rather than assembled annually.
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Self-assessment
Data & AI Maturity
See how ready your data actually is for the AI work you're planning.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
-
Market comparison
Pharma Data Platform Use Cases — Ranked
Use cases ranked by how hard they are against what they're worth.
Think we've read this right?
Talk to usRelated reading
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Developing a data and technology-driven flexible lab operations model
Now, when it becomes clear to the biotech companies that only by sharing the data they can thrive, everyone is looking for a solution.
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
-
Cybersecurity for industrial automation and control systems in Life Sciences
Pharma specific hardware and software development is far more complex than only Cybersecurity, but securely designed Product may address...
-
Addressing sustainability in pharma & biotech
At A4BEE, we combine company social responsibility and sustainability needs with the path set by the company’s values and mission.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Bestpharma Sp. z o.o., and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].